作者: Oleksii S. Rukhlenko , Fahimeh Khorsand , Aleksandar Krstic , Jan Rozanc , Leonidas G. Alexopoulos
DOI: 10.1016/J.CELS.2018.06.002
关键词: Cell culture 、 Cell biology 、 Neuroblastoma RAS viral oncogene homolog 、 HRAS 、 Mutant 、 Cell growth 、 MAPK/ERK pathway 、 Chemistry 、 Cell 、 Inhibitor resistance
摘要: Clinically used RAF inhibitors are ineffective in RAS mutant tumors because they enhance homo-and heterodimerization of RAF kinases, leading to paradoxical activation of ERK …